Ozalp FR, Ellez HI, Arslan AM, Demirciler E, et al. Integrative in silico transcriptomic and pharmacogenomic analysis of CD276 as a
candidate prognostic biomarker and therapeutic target in bladder cancer. Discov Oncol 2026 May 25. doi: 10.1007/s12672-026-05310.
PMID: 42185660
|